Lymphoplasmacytic plaque effectively treated with imiquimod

Ital J Dermatol Venerol. 2021 Dec;156(Suppl. 1 to No. 6):17-18. doi: 10.23736/S2784-8671.19.06214-X. Epub 2019 Apr 23.

Authors

Martina Maurelli¹, Chiara Colato², Luca Giannetti³, Giampiero Girolomoni⁴

Affiliations

¹ Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy - maurelli.martina@gmail.com.
² Section of Pathology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
³ Unit of Dentistry and Oral-Maxillo-Facial Surgery, University of Modena and Reggio Emilia, Modena, Italy.
⁴ Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.

PMID: 31042850
DOI: 10.23736/S2784-8671.19.06214-X

No abstract available

MeSH terms

Aminoquinolines / therapeutic use
Humans
Imiquimod / therapeutic use
Plaque, Atherosclerotic*
Skin Abnormalities*
Skin Neoplasms*

Substances

Aminoquinolines
Imiquimod